Given the role that aldosterone plays in causing hypertension and promoting cardiovascular and kidney disease, the direct blockade of aldosterone synthesis by inhibiting aldosterone synthase (AS), a specific enzyme that is involved in the generation of aldosterone, may represent a novel but effective alternative approach compared to treatments with MRAs. This evidence concerns the gene CYP11B2 and hypertensive disorder.